“The new ATEC continues to attract the best and brightest in spine, and I am thrilled to welcome these outstanding individuals to the family,” said Pat Miles, chairman and CEO. “I’m looking forward to working closely with Mark again to bring profound innovation to a market that is ripe for it. His proven expertise will elevate our sophistication in cervical and biologics, two key segments of the market where ATEC currently is underrepresented. He has unsurpassed business-building know-how, a passion for developing surgeon partners to drive market adoption, and a depth of experience with integrating multiple technologies into highly differentiated procedural solutions. We are clearly assembling the most accomplished, effective talent in the industry, and with Mark’s addition, our cervical spine team is second to none.”
As a leader in the orthopedic/spine industry, Ojeda brings a 25-year track record of successfully leading marketing and product development teams and has successfully commercialized cervical and biologics products and procedural solutions that have collectively generated hundreds of millions in revenue. He joins ATEC following a 12-year tenure at NuVasive Inc., where he most recently was vice president of Cervicothoracic Systems, credited with leading the evolution of the product portfolio and transforming the cervical product team. In his previous role as NuVasive’s vice president of Global Integrated Products and Services, Ojeda was responsible for integrating intraoperative monitoring and biologics technologies across the lumbar and cervical business units. Prior to joining NuVasive, he held various leadership roles at Smith & Nephew plc and Medtronic Sofamor Danek.
Wilson joins ATEC following 15 years in sales and sales management roles with Stryker Spine, where he was consistently recognized for outstanding sales performance. Zabel joins ATEC following more than 13 years in sales and sales management positions at both DePuy Synthes and Stryker Spine, where he helped to substantially grow the minimally invasive surgery (MIS) division.
Alphatec Holdings Inc., through its wholly-owned subsidiaries, Alphatec Spine Inc. and SafeOp Surgical Inc., designs, develops, and markets technology for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The company's mission is to improve lives by providing innovative spine surgery solutions through the pursuit of superior outcomes. The company markets its products in the United States via independent sales agents and a direct sales force.